AGEN
Price
$4.63
Change
+$0.24 (+5.47%)
Updated
Aug 26 closing price
Capitalization
147.53M
AUTL
Price
$1.61
Change
+$0.01 (+0.62%)
Updated
Aug 26 closing price
Capitalization
428.49M
64 days until earnings call
Interact to see
Advertisement

AGEN vs AUTL

Header iconAGEN vs AUTL Comparison
Open Charts AGEN vs AUTLBanner chart's image
Agenus
Price$4.63
Change+$0.24 (+5.47%)
Volume$507.12K
Capitalization147.53M
Autolus Therapeutics
Price$1.61
Change+$0.01 (+0.62%)
Volume$3.28M
Capitalization428.49M
AGEN vs AUTL Comparison Chart in %
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGEN vs. AUTL commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Buy and AUTL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (AGEN: $4.63 vs. AUTL: $1.61)
Brand notoriety: AGEN and AUTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 51% vs. AUTL: 157%
Market capitalization -- AGEN: $147.53M vs. AUTL: $428.49M
AGEN [@Biotechnology] is valued at $147.53M. AUTL’s [@Biotechnology] market capitalization is $428.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileAUTL’s FA Score has 1 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • AUTL’s FA Score: 1 green, 4 red.
According to our system of comparison, AUTL is a better buy in the long-term than AGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 5 TA indicator(s) are bullish while AUTL’s TA Score has 4 bullish TA indicator(s).

  • AGEN’s TA Score: 5 bullish, 5 bearish.
  • AUTL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AGEN is a better buy in the short-term than AUTL.

Price Growth

AGEN (@Biotechnology) experienced а +2.21% price change this week, while AUTL (@Biotechnology) price change was -10.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.28%. For the same industry, the average monthly price growth was +23.07%, and the average quarterly price growth was +32.06%.

Reported Earning Dates

AUTL is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+4.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUTL($428M) has a higher market cap than AGEN($148M). AGEN YTD gains are higher at: 68.978 vs. AUTL (-31.489). AGEN has higher annual earnings (EBITDA): -74.93M vs. AUTL (-232.19M). AUTL has more cash in the bank: 454M vs. AGEN (9.53M). AUTL has less debt than AGEN: AUTL (64.5M) vs AGEN (90.5M). AGEN has higher revenues than AUTL: AGEN (102M) vs AUTL (29.9M).
AGENAUTLAGEN / AUTL
Capitalization148M428M35%
EBITDA-74.93M-232.19M32%
Gain YTD68.978-31.489-219%
P/E Ratio0.16N/A-
Revenue102M29.9M341%
Total Cash9.53M454M2%
Total Debt90.5M64.5M140%
FUNDAMENTALS RATINGS
AGEN vs AUTL: Fundamental Ratings
AGEN
AUTL
OUTLOOK RATING
1..100
853
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6065
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AUTL's Valuation (22) in the Biotechnology industry is significantly better than the same rating for AGEN (97). This means that AUTL’s stock grew significantly faster than AGEN’s over the last 12 months.

AUTL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AGEN (100). This means that AUTL’s stock grew similarly to AGEN’s over the last 12 months.

AUTL's SMR Rating (97) in the Biotechnology industry is in the same range as AGEN (100). This means that AUTL’s stock grew similarly to AGEN’s over the last 12 months.

AGEN's Price Growth Rating (60) in the Biotechnology industry is in the same range as AUTL (65). This means that AGEN’s stock grew similarly to AUTL’s over the last 12 months.

AGEN's P/E Growth Rating (97) in the Biotechnology industry is in the same range as AUTL (100). This means that AGEN’s stock grew similarly to AUTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGENAUTL
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGEWX10.740.01
+0.09%
Baillie Gifford Emer Mkt Ex Chn Instl
SGQCX42.18N/A
N/A
DWS International Growth C
JACNX29.87N/A
N/A
Janus Henderson Contrarian D
UIVAX20.17N/A
N/A
Victory Value Institutional
LONAX14.89N/A
N/A
Longboard A

AGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with TAOX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
+5.47%
TAOX - AGEN
91%
Closely correlated
-0.71%
ALLR - AGEN
87%
Closely correlated
+51.92%
PALI - AGEN
81%
Closely correlated
-1.70%
AXON - AGEN
42%
Loosely correlated
+0.72%
ELVN - AGEN
40%
Loosely correlated
+1.88%
More

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with OCUL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
+0.62%
OCUL - AUTL
48%
Loosely correlated
+3.79%
SCPH - AUTL
46%
Loosely correlated
+0.18%
CRSP - AUTL
44%
Loosely correlated
+1.39%
LRMR - AUTL
44%
Loosely correlated
+4.03%
IMCR - AUTL
41%
Loosely correlated
+0.06%
More